CONDENSED CONSOLIDATED AND COMBINED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2017	Mar. 31, 2016
Cash flows from operating activities:
Net income (loss)	$ (27,205)	$ (4,687)
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:
Depreciation and amortization	22,120	31,157
Non-cash interest expense	730	0
Provision for (benefit from) deferred income taxes	601	0
Stock-based compensation expense	2,797	0
Impairment of long-lived assets and goodwill	3,300	0
Loss (gain) on sale of hospitals, net	(870)	0
Changes in reserves for self-insurance claims, net of payments	4,212	7,990
Changes in reserves for legal, professional and settlement costs, net of payments	(3,651)	0
Other non-cash expense (income), net	(42)	(554)
Changes in operating assets and liabilities, net of acquisitions and divestitures:
Patient accounts receivable, net	(17,163)	(12,122)
Due from and due to third-party payors, net	11,041	12,339
Inventories, prepaid expenses and other current assets	(16,674)	(2,589)
Accounts payable and accrued liabilities	38,065	(7,626)
Long-term assets and liabilities, net	1,265	489
Net cash provided by (used in) operating activities	18,526	24,397
Cash flows from investing activities:
Capital expenditures for property and equipment	(23,217)	(12,840)
Capital expenditures for software	(1,506)	(2,526)
Proceeds from the sale of hospitals	4,282	0
Proceeds from other asset sales	0	858
Other investing activities	0	52
Net cash provided by (used in) investing activities	(20,441)	(14,456)
Cash flows from financing activities:
Borrowings (repayments) of revolving credit facilities, net	78,000	0
Borrowings of long-term debt	0	20
Repayments of long-term debt	(7,109)	(1,089)
Increase (decrease) in Due to Parent, net	0	(6,486)
Payments of debt issuance costs	(47)	0
Cancellation of restricted stock awards for payroll tax withholdings on vested shares	(1,028)	0
Cash distributions to noncontrolling investors	(3,814)	(2,484)
Purchases of shares from noncontrolling investors	0	(12)
Net cash provided by (used in) financing activities	66,002	(10,051)
Net change in cash and cash equivalents	64,087	(110)
Cash and cash equivalents at beginning of period	25,455	1,106
Cash and cash equivalents at end of period	89,542	996
Supplemental cash flow information:
Interest payments, net	15,468	27,452
Income tax payments, net of refunds (after the Spin-off)	0	0
Non-cash purchases of property and equipment under capital lease obligations	$ 0	$ 2,023